Finance

Lists
Why is 6446 up 2,55%?
Dive Deeper
6446:TPE
PharmaEssentia Corp
1 205,00 NT$
+2,55%
(+30,00) 1D
7 ოქტ, 13:30:13 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6446...
Open
1 180,00 NT$
High
1 215,00 NT$
Low
1 165,00 NT$
Mkt. cap
514,06 მლრ.
Avg. vol.
3,78 მლნ.
Volume
1,49 მლნ.
Dividend
0,11%
Quarterly dividend
0,34 NT$
Ex-dividend date
11 აგვ. 2025
P/E ratio
67,31
52-wk high
1 645,00 NT$
52-wk low
407,92 NT$
EPS
17,90 NT$
No. of employees
131
Open
1 180,00 NT$
High
1 215,00 NT$
Low
1 165,00 NT$
Mkt. cap
514,06 მლრ.
Avg. vol.
3,78 მლნ.
Volume
1,49 მლნ.
Dividend
0,11%
Quarterly dividend
0,34 NT$
Ex-dividend date
11 აგვ. 2025
P/E ratio
67,31
52-wk high
1 645,00 NT$
52-wk low
407,92 NT$
EPS
17,90 NT$
No. of employees
131
News stories
From web sources and news partners
About PharmaEssentia Corp
CEO-
Employees131
Founded9 მაი. 1990
Headquarters-
Sector-
Websitepharmaessentia.com
Last report
12 აგვ. 2026
Fiscal period
Q2 2026
EPS / Est. (TWD)
6,13 NT$ / 6,23 NT$
-1,66%miss
Revenue / Est. (TWD)
6,86 მლრდ. / 6,74 მლრდ.
+1,72%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
3,89 მლრდ.
4,88 მლრდ.
5,12 მლრდ.
6,86 მლრდ.
Cost of goods sold
327,93 მლნ.
543,68 მლნ.
621,28 მლნ.
395,45 მლნ.
Cost of revenue
327,93 მლნ.
543,68 მლნ.
621,28 მლნ.
395,45 მლნ.
Research and development expenses
884,63 მლნ.
1,01 მლრდ.
857,29 მლნ.
1,07 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,52 მლრდ.
1,77 მლრდ.
1,56 მლრდ.
2,24 მლრდ.
Operating expense
2,40 მლრდ.
2,78 მლრდ.
2,41 მლრდ.
3,31 მლრდ.
Total operating expenses
2,73 მლრდ.
3,32 მლრდ.
3,03 მლრდ.
3,70 მლრდ.
Operating income
1,17 მლრდ.
1,56 მლრდ.
2,09 მლრდ.
3,15 მლრდ.
Other non operating income
238,00 ათ.
4,37 მლნ.
1,32 მლნ.
8,58 მლნ.
EBT including unusual items
1,41 მლრდ.
2,01 მლრდ.
2,34 მლრდ.
3,20 მლრდ.
EBT excluding unusual items
1,41 მლრდ.
2,01 მლრდ.
2,34 მლრდ.
3,20 მლრდ.
Income tax expense
-59,18 მლნ.
536,45 მლნ.
185,95 მლნ.
668,64 მლნ.
Effective tax rate
-4,19%
26,65%
7,96%
20,90%
Other operating expenses
-
-
-
-
Net income
1,47 მლრდ.
1,48 მლრდ.
2,15 მლრდ.
2,53 მლრდ.
Net profit margin
37,83%
30,24%
41,97%
36,90%
Earnings per share
3,60
3,58
5,21
6,13
Interest and investment income
123,73 მლნ.
142,46 მლნ.
139,53 მლნ.
148,04 მლნ.
Interest expense
-5,55 მლნ.
-5,76 მლნ.
-4,71 მლნ.
-5,95 მლნ.
Net interest expenses
118,18 მლნ.
136,70 მლნ.
134,82 მლნ.
142,08 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,20 მლრდ.
1,60 მლრდ.
2,14 მლრდ.
3,21 მლრდ.
Gain or loss from assets sale
-
1,50 მლნ.
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები